MERRIMACK PHARMACEUTICALS IN's ticker is MACKXXXX and the CUSIP is 590328100. A total of 133 filers reported holding MERRIMACK PHARMACEUTICALS IN in Q3 2014. The put-call ratio across all filers is 0.85 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $43,000 | -60.2% | 35,277 | 0.0% | 0.00% | – |
| Q1 2017 | $108,000 | -28.5% | 35,277 | -4.1% | 0.00% | – |
| Q4 2016 | $151,000 | -5.0% | 36,791 | +45.6% | 0.00% | – |
| Q3 2016 | $159,000 | +10.4% | 25,270 | -5.6% | 0.00% | – |
| Q2 2016 | $144,000 | -36.3% | 26,766 | 0.0% | 0.00% | – |
| Q1 2016 | $226,000 | +49.7% | 26,766 | +40.6% | 0.00% | – |
| Q4 2015 | $151,000 | -5.0% | 19,034 | 0.0% | 0.00% | – |
| Q3 2015 | $159,000 | -14.1% | 19,034 | +24.3% | 0.00% | – |
| Q2 2015 | $185,000 | +1.6% | 15,312 | 0.0% | 0.00% | – |
| Q1 2015 | $182,000 | +5.2% | 15,312 | 0.0% | 0.00% | – |
| Q4 2014 | $173,000 | +24.5% | 15,312 | -3.4% | 0.00% | – |
| Q3 2014 | $139,000 | – | 15,849 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lagoda Investment Management, L.P. | 1,560,530 | $17,634,000 | 4.71% |
| B & T Capital Management DBA Alpha Capital Management | 280,113 | $3,165,000 | 2.22% |
| Schonfeld Group Holdings LLC | 10,000 | $113,000 | 1.51% |
| COLUMBIA CAPITAL LLC | 117,702 | $1,331,000 | 1.45% |
| Portolan Capital Management | 607,288 | $6,862,000 | 1.38% |
| Price Capital Management, Inc. | 118,047 | $1,334,000 | 1.18% |
| GARRISON BRADFORD & ASSOCIATES INC | 90,700 | $1,025,000 | 0.93% |
| Opus Point Partners Management, LLC | 72,009 | $814,000 | 0.80% |
| EAM Investors, LLC | 412,233 | $4,658,000 | 0.65% |
| TFS CAPITAL LLC | 476,105 | $5,380,000 | 0.51% |